Literature DB >> 9351626

Interleukin-1 in ischemia-reperfusion acute lung injury.

D M Chang1, K Hsu, Y A Ding, C H Chiang.   

Abstract

Interleukin-1 (IL-1) is a proinflammatory cytokine produced by blood-borne and resident inflammatory lung tissue involved in the thrombotic occlusion of the pulmonary microcirculation and the increase of the vascular permeability following a wide variety of injuries and sepsis. The locally accentuated, organ-related activation of this cytokine seems to be responsible for the development of acute lung injury. The present study was conducted to determine if IL-1beta was produced in an ischemia-reperfusion (I/R) rat model subjected to lung injury. We measured sequential perfusate levels of IL-1beta by ELISA and we measured IL-1 gene expression in the rat lung tissue by a reverse-transcriptase polymerase chain reaction method. Little IL-1beta gene expression was observed in normal rat lung tissue. Perfusate IL-1beta slightly increased 2 h after induced ischemia and 3 h after reperfusion. IL-1beta gene expression rapidly increased as early as 30 min after ischemia and continued to increase for up to 120 min. IL-1beta gene expression was dramatically upregulated during reperfusion after cessation of ischemia, reached a peak at 1 h, and then gradually decreased (2 to 3 h) to near baseline levels. During ischemia, the increased IL-1 gene expression was not significantly different between the ventral and dorsal sites of the lung. However, IL-1 gene expression markedly increased on the dorsal part (the dependent site for a rat in a supine position) after reperfusion. From these results, it appears that IL-1 may have an important role in I/R lung injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351626     DOI: 10.1164/ajrccm.156.4.9702095

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Reduced-flow ex vivo lung perfusion to rehabilitate lungs donated after circulatory death.

Authors:  Jared P Beller; Matthew R Byler; Dustin T Money; William Z Chancellor; Aimee Zhang; Yunge Zhao; Mark H Stoler; Adishesh K Narahari; Alexander Shannon; J Hunter Mehaffey; Curtis G Tribble; Victor E Laubach; Irving L Kron; Mark E Roeser
Journal:  J Heart Lung Transplant       Date:  2019-09-18       Impact factor: 10.247

2.  Integrin alphavbeta5 regulates lung vascular permeability and pulmonary endothelial barrier function.

Authors:  George Su; Maki Hodnett; Nanyan Wu; Amha Atakilit; Cynthia Kosinski; Mika Godzich; Xiao Zhu Huang; Jiyeun K Kim; James A Frank; Michael A Matthay; Dean Sheppard; Jean-François Pittet
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

3.  Apocynin attenuates ventilator-induced lung injury in an isolated and perfused rat lung model.

Authors:  Chi-Huei Chiang; Chiao-Hui Chuang; Shiou-Ling Liu; Tzong-Shyuan Lee; Yu Ru Kou; Haibo Zhang
Journal:  Intensive Care Med       Date:  2011-05-27       Impact factor: 17.440

Review 4.  Inflammatory response to pulmonary ischemia-reperfusion injury.

Authors:  Calvin S H Ng; Song Wan; Ahmed A Arifi; Anthony P C Yim
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.

Authors:  Anders S I Andreasson; Lee A Borthwick; Colin Gillespie; Kasim Jiwa; Jonathan Scott; Paul Henderson; Jonny Mayes; Rosalba Romano; Marius Roman; Simi Ali; James E Fildes; Nandor Marczin; John H Dark; Andrew J Fisher
Journal:  J Heart Lung Transplant       Date:  2017-05-12       Impact factor: 10.247

Review 6.  Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers.

Authors:  Nicole E Speck; Macé M Schuurmans; Christian Benden; Cécile A Robinson; Lars C Huber
Journal:  Respir Res       Date:  2017-08-07

7.  Intravascular donor monocytes play a central role in lung transplant ischaemia-reperfusion injury.

Authors:  Kate Colette Tatham; Kieran Patrick O'Dea; Rosalba Romano; Hannah Elizabeth Donaldson; Kenji Wakabayashi; Brijesh Vipin Patel; Louit Thakuria; Andre Rudiger Simon; Padmini Sarathchandra; Nandor Marczin; Masao Takata
Journal:  Thorax       Date:  2017-04-07       Impact factor: 9.139

8.  Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury.

Authors:  Yung-Yang Liu; Chi-Huei Chiang; Shih-Chieh Hung; Chih-Feng Chian; Chen-Liang Tsai; Wei-Chih Chen; Haibo Zhang
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.